CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Cytotoxic CD4(+) T cells in cancer: Expanding the immune effector toolbox.
Cytotoxic CD4(+) T cells in cancer: Expanding the immune effector toolbox.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
细胞毒性T细胞是抗肿瘤免疫的重要效应细胞。虽然肿瘤杀伤通常归因于CD8+ T细胞功能,但临床前和临床研究已发现肿瘤内CD4+ T细胞具有细胞毒性程序,能够直接杀伤癌细胞。细胞毒性CD4+ T细胞也存在于感染和自身免疫等其他疾病环境中。在此,我们综述了细胞毒性CD4+ T细胞在非癌症和癌症背景下的表型和功能特征。我们对细胞毒性CD4+ T细胞在不同疾病状态下的细胞溶解机制进行了比较研究,并综合了不依赖于背景的定义这些细胞的特征。我们讨论了驱动其个体发生和效应功能的调控机制,以及细胞毒性CD4+ T细胞在癌症中临床相关性的证据。在此背景下,我们强调了在理解细胞毒性CD4+ T细胞生物学方面的重要空白,以及这些细胞在特定癌症免疫治疗中的潜在应用。
Cytotoxic T cells are important effectors of anti-tumor immunity. While tumor killing is ascribed to CD8 + T cell function, pre-clinical and clinical studies have identified intra-tumoral CD4 + T cells that possess cytotoxic programs and can directly kill cancer cells. Cytotoxic CD4 + T cells are found in other disease settings including infection and autoimmunity.
Here, we review the phenotypic and functional characteristics of cytotoxic CD4 + T cells in non-cancer and cancer contexts.
We conduct a comparative examination of cytolytic mechanisms of cytotoxic CD4 + T cells across disease states and synthesize features that define these cells independent of context.
We discuss regulatory mechanisms driving ontogeny and effector function and evidence for the clinical relevance of cytotoxic CD4 + T cells in cancer. In this context, we highlight important gaps in understanding in the biology of cytotoxic CD4 + T cells as well as the potential use of these cells in immunotherapies for specific cancers.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。